Literature DB >> 9282608

Cervical spine involvement in rheumatoid arthritis: prevalence and relationship with overall disease severity.

A Aggarwal1, A Kulshreshtha, V Chaturvedi, R Misra.   

Abstract

Rheumatoid arthritis (RA) affects the cervical spine in 20-90% of patients in Western countries. We report the prevalence of cervical spine involvement in RA and its relationship with duration of disease, seropositivity, hand joint erosions and symptoms and signs suggestive of cervical spine involvement. 100 patients with RA criteria were included. Apart from clinical history and examination, study included X-rays of the cervical spine in AP, open mouth and lateral views and posteroanterior view of hands and rheumatoid factor estimation. All X-rays were read by a radiologist who was unaware of the clinical details. Cervical spine involvement was seen in 65% of patients. The commonest abnormality was erosions of the odontoid process (47%), followed by atlanto-axial dislocation and apophyseal joint involvement (24%). Only 5% of patients had abnormalities of spinous processes or vertebral bodies. Patients with abnormal cervical spine radiographs had higher prevalence of rheumatoid factor and erosions on hand radiographs. Severity of cervical spine changes was related to duration of disease (> 5 years). No correlation was seen between symptoms and radiological abnormalities except when neurological deficit was present. Patients with seropositivity, erosive disease and disease duration greater than five years should be screened for cervical spine disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9282608

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  8 in total

1.  Posterior Fusion in Patients with Trauma, Instability, and Tumor of the Cervical Spine.

Authors:  Dr Hans-Joachim Riesner; Sebastian Katscher; Thomas Blattert; Christoph Josten
Journal:  Eur J Trauma Emerg Surg       Date:  2009-05-07       Impact factor: 3.693

2.  Influence of systemic bone mineral density on atlantoaxial subluxation in patients with rheumatoid arthritis.

Authors:  M H Han; J I Ryu; C H Kim; J M Kim; J H Cheong; K H Bak; H J Chun
Journal:  Osteoporos Int       Date:  2017-03-02       Impact factor: 4.507

3.  Prevalence of cervical spine instability among Rheumatoid Arthritis patients in South Iraq.

Authors:  Husham A Al-Daoseri; Mubder A Mohammed Saeed; Rafal A Ahmed
Journal:  J Clin Orthop Trauma       Date:  2019-06-14

4.  Magnetic resonance imaging of the craniovertebral junction in early rheumatoid arthritis.

Authors:  Marina Carotti; Fausto Salaffi; Marco Di Carlo; Francesco Sessa; Andrea Giovagnoni
Journal:  Skeletal Radiol       Date:  2018-09-11       Impact factor: 2.199

5.  Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis.

Authors:  Tony Zhang; Janet Pope
Journal:  Arthritis Res Ther       Date:  2015-05-31       Impact factor: 5.156

6.  Is It the Age at Disease Onset or the Disease Radiological Severity That Affects Cervical Spine Involvement in Patients With Rheumatoid Arthritis?

Authors:  Hanan Sayed M Abozaid; Reham Alaa El-Din Hassan; Waleed A Elmadany; Mohamed Aly Ismail; Dalia S Elgendy; Sahar A Elsayed; Rania M Gamal; Osama S Daifallah; Esam M Abu Alfadl
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2018-02-20

7.  A not-to-miss Cause of Severe Cervical Spine Pain in a Patient with Rheumatoid Arthritis: A Case-Based Review.

Authors:  Alexandros A Drosos; Eleftherios Pelechas; Athanasios N Georgiadis; Paraskevi V Voulgari
Journal:  Mediterr J Rheumatol       Date:  2021-08-25

8.  Rationale and design of The Delphi Trial--I(RCT)2: international randomized clinical trial of rheumatoid craniocervical treatment, an intervention-prognostic trial comparing 'early' surgery with conservative treatment [ISRCTN65076841].

Authors:  Jasper F C Wolfs; Wilco C Peul; Maarten Boers; Maurits W van Tulder; Ronald Brand; Hans J C van Houwelingen; Raph T W M Thomeer
Journal:  BMC Musculoskelet Disord       Date:  2006-02-16       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.